↓ Skip to main content

Dove Medical Press

Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 241)
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
5 patents

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
30 Mendeley
Title
Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients
Published in
International Journal of Nephrology and Renovascular Disease, May 2014
DOI 10.2147/ijnrd.s41626
Pubmed ID
Authors

Shahrzad Ossareh

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Israel 1 3%
Canada 1 3%
Unknown 28 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 20%
Student > Master 6 20%
Student > Bachelor 5 17%
Other 2 7%
Student > Doctoral Student 1 3%
Other 5 17%
Unknown 5 17%
Readers by discipline Count As %
Medicine and Dentistry 14 47%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Nursing and Health Professions 3 10%
Psychology 2 7%
Business, Management and Accounting 1 3%
Other 2 7%
Unknown 5 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#5,340,716
of 25,584,565 outputs
Outputs from International Journal of Nephrology and Renovascular Disease
#50
of 241 outputs
Outputs of similar age
#48,583
of 242,530 outputs
Outputs of similar age from International Journal of Nephrology and Renovascular Disease
#6
of 11 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 241 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.